PL367632A1 - Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-$g(a), $g(a)-dimethylbenzene acetic acid and its hydrochloride - Google Patents
Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-$g(a), $g(a)-dimethylbenzene acetic acid and its hydrochlorideInfo
- Publication number
- PL367632A1 PL367632A1 PL01367632A PL36763201A PL367632A1 PL 367632 A1 PL367632 A1 PL 367632A1 PL 01367632 A PL01367632 A PL 01367632A PL 36763201 A PL36763201 A PL 36763201A PL 367632 A1 PL367632 A1 PL 367632A1
- Authority
- PL
- Poland
- Prior art keywords
- piperindinyl
- hydroxydiphenylmethyl
- hydroxybutyl
- hydrochloride
- acetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN484MA2001 | 2001-06-18 | ||
| PCT/US2001/023994 WO2002102777A2 (en) | 2001-06-18 | 2001-07-31 | NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL367632A1 true PL367632A1 (en) | 2005-03-07 |
Family
ID=34566868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01367632A PL367632A1 (en) | 2001-06-18 | 2001-07-31 | Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-$g(a), $g(a)-dimethylbenzene acetic acid and its hydrochloride |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP1399422A2 (en) |
| JP (2) | JP2005507374A (en) |
| KR (1) | KR20040015734A (en) |
| CN (1) | CN100390145C (en) |
| AU (1) | AU2001278094B2 (en) |
| BG (1) | BG108435A (en) |
| BR (1) | BR0117054A (en) |
| CA (2) | CA2450858C (en) |
| CO (1) | CO5540340A2 (en) |
| CZ (1) | CZ20033358A3 (en) |
| EE (1) | EE200400010A (en) |
| HU (1) | HUP0401546A2 (en) |
| IL (2) | IL159266A0 (en) |
| MX (1) | MXPA03011728A (en) |
| NZ (1) | NZ530118A (en) |
| PL (1) | PL367632A1 (en) |
| RU (1) | RU2269516C2 (en) |
| SK (1) | SK15372003A3 (en) |
| WO (1) | WO2002102777A2 (en) |
| ZA (1) | ZA200309557B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1392303A4 (en) * | 2001-04-09 | 2005-01-26 | Teva Pharma | Polymorphs of fexofenadine hydrochloride |
| WO2003104197A1 (en) * | 2002-06-10 | 2003-12-18 | Teva Pharmaceutical Industries Ltd. | Polymorphic form xvi of fexofenadine hydrochloride |
| GB0319935D0 (en) * | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| KR20070007196A (en) * | 2004-04-26 | 2007-01-12 | 테바 파마슈티컬 인더스트리즈 리미티드 | Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
| ITMI20041143A1 (en) * | 2004-06-08 | 2004-09-08 | Dipharma Spa | FEXOFENADINA POLYMORPHS AND PROCEDURE FOR THEIR PREPARATION |
| ITMI20041568A1 (en) * | 2004-07-30 | 2004-10-30 | Dipharma Spa | "BASE FEXOFENADINA POLYMORPHS" |
| JP2008514641A (en) * | 2004-09-28 | 2008-05-08 | テバ ファーマシューティカル インダストリーズ リミティド | Crystalline fexofenadine and method for its preparation |
| WO2007007347A1 (en) * | 2005-07-07 | 2007-01-18 | Wockhardt Limited | Industrial process of fexofenadine hydrochloride with controlled side products |
| US20090306135A1 (en) | 2008-03-24 | 2009-12-10 | Mukesh Kumar Sharma | Stable amorphous fexofenadine hydrochloride |
| CN104072402B (en) * | 2014-07-16 | 2016-08-17 | 昆山龙灯瑞迪制药有限公司 | A kind of fexofenadine hydrochloride compound of new crystalline form and preparation method thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| EP2354125A1 (en) * | 1994-05-18 | 2011-08-10 | Aventisub II Inc. | Anhydrous and hydrate polymorphic forms of antihistaminic piperidine derivatives |
| US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| IN191492B (en) | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
| GB0018691D0 (en) * | 2000-07-28 | 2000-09-20 | Rolabo Sl | Process |
-
2001
- 2001-07-31 MX MXPA03011728A patent/MXPA03011728A/en active IP Right Grant
- 2001-07-31 CZ CZ20033358A patent/CZ20033358A3/en unknown
- 2001-07-31 EP EP01956057A patent/EP1399422A2/en not_active Withdrawn
- 2001-07-31 HU HU0401546A patent/HUP0401546A2/en unknown
- 2001-07-31 EP EP10010066A patent/EP2261209A1/en not_active Withdrawn
- 2001-07-31 KR KR10-2003-7016163A patent/KR20040015734A/en not_active Application Discontinuation
- 2001-07-31 WO PCT/US2001/023994 patent/WO2002102777A2/en active IP Right Grant
- 2001-07-31 IL IL15926601A patent/IL159266A0/en unknown
- 2001-07-31 NZ NZ530118A patent/NZ530118A/en unknown
- 2001-07-31 EE EEP200400010A patent/EE200400010A/en unknown
- 2001-07-31 JP JP2003505320A patent/JP2005507374A/en active Pending
- 2001-07-31 CA CA002450858A patent/CA2450858C/en not_active Expired - Fee Related
- 2001-07-31 RU RU2004101045/04A patent/RU2269516C2/en not_active IP Right Cessation
- 2001-07-31 BR BR0117054-6A patent/BR0117054A/en not_active Application Discontinuation
- 2001-07-31 PL PL01367632A patent/PL367632A1/en not_active Application Discontinuation
- 2001-07-31 SK SK1537-2003A patent/SK15372003A3/en unknown
- 2001-07-31 CA CA002646802A patent/CA2646802A1/en not_active Abandoned
- 2001-07-31 CN CNB018233791A patent/CN100390145C/en not_active Expired - Fee Related
- 2001-07-31 AU AU2001278094A patent/AU2001278094B2/en not_active Ceased
-
2003
- 2003-12-09 ZA ZA200309557A patent/ZA200309557B/en unknown
- 2003-12-09 IL IL159266A patent/IL159266A/en not_active IP Right Cessation
- 2003-12-11 BG BG108435A patent/BG108435A/en unknown
- 2003-12-18 CO CO03110519A patent/CO5540340A2/en not_active Application Discontinuation
-
2007
- 2007-11-06 JP JP2007289084A patent/JP2008094848A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2450858C (en) | 2009-04-07 |
| CO5540340A2 (en) | 2005-07-29 |
| EP2261209A1 (en) | 2010-12-15 |
| EP1399422A2 (en) | 2004-03-24 |
| NZ530118A (en) | 2007-05-31 |
| WO2002102777A2 (en) | 2002-12-27 |
| HUP0401546A2 (en) | 2004-12-28 |
| CN1518540A (en) | 2004-08-04 |
| IL159266A0 (en) | 2004-06-01 |
| KR20040015734A (en) | 2004-02-19 |
| CA2450858A1 (en) | 2002-12-27 |
| WO2002102777A3 (en) | 2003-02-27 |
| SK15372003A3 (en) | 2004-08-03 |
| IL159266A (en) | 2010-11-30 |
| JP2005507374A (en) | 2005-03-17 |
| ZA200309557B (en) | 2004-09-14 |
| BG108435A (en) | 2004-12-30 |
| BR0117054A (en) | 2004-07-27 |
| CZ20033358A3 (en) | 2004-04-14 |
| MXPA03011728A (en) | 2004-07-08 |
| WO2002102777A8 (en) | 2003-10-30 |
| RU2004101045A (en) | 2005-06-27 |
| EE200400010A (en) | 2004-02-16 |
| RU2269516C2 (en) | 2006-02-10 |
| CN100390145C (en) | 2008-05-28 |
| CA2646802A1 (en) | 2002-12-27 |
| AU2001278094B2 (en) | 2006-01-12 |
| JP2008094848A (en) | 2008-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL367632A1 (en) | Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-$g(a), $g(a)-dimethylbenzene acetic acid and its hydrochloride | |
| EE200400019A (en) | Polymorphic forms of 1- [4- (5-cyanoindol-3-yl) butyl] -4- (2-carbamoylbenzofuran-5-yl) piperazine hydrochloride | |
| IL146707A0 (en) | Novel use of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbamoyl-benzofuran-5-yl)- piperazine and its physiologically acceptable salts | |
| IL133917A0 (en) | Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives | |
| IL162484A (en) | Pyrrolidine and piperidine derivatives as nk1 antagonists | |
| CA2200356A1 (en) | Process for preparing levobupivacaine and analogues thereof | |
| AU2002360561A1 (en) | 4-substituted piperidines, and methods of use thereof | |
| IS7271A (en) | Piperdine and piperazine derivatives 2,4-disubstituted, 3,5-disubstituted and 3,4,5-sumstituted piperadines and piperazines | |
| WO2001094313A3 (en) | Crystal modification of fexofenadine | |
| IL162666A0 (en) | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof | |
| PL325264A1 (en) | Novel derivatives of phenyl-alpha,alpha-dimethylacetic acid, method of obtaining such derivatives, method of obtaining a pharmaceutic agent, application of such derivatives and method of obtaining 4-{4-[4-(hydroxydiphenylmethyl)piperidin]-1-hydroxybutyl}-phenyl-alpha,alpha-dimethylacetic acid | |
| HUP0201673A3 (en) | Process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-alpha, alpha-dimethylbenzeneacetic acid | |
| DK1531151T3 (en) | Process for Preparation of 1-Benzyl-4 - [(5,6-dimethoxy-1-indanone) -2-yl] methylpiperidine hydrochloride | |
| NZ306319A (en) | 1-alkylphenyl substituted 4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butanol derivatives and medicaments | |
| WO2002100847A3 (en) | Factor xa inhibitor | |
| NO20040479L (en) | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride. | |
| IL152570A0 (en) | A process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-alpha, alpha-di methylbenzeneacetic acid | |
| IL161521A0 (en) | N-formyl derivatives of paroxetine | |
| HK1062683A1 (en) | Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(E)-=-methyloxime and its salts. | |
| NO20042946L (en) | Piperidine-2,6-dione heterocyclic substituted at position 3 | |
| CA2188507A1 (en) | Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same | |
| AU2002359274A1 (en) | Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts | |
| AU2003300259A1 (en) | Crystalline 2- `(2-aminoethoxy) methyl!-4-(2-chlorophenyl) -3-ethoxycarbonyl-5-methoxycarbonyl-6- methyl-1, 4-dihydropyridine maleate salt (amplodipine) | |
| WO2001005764A3 (en) | Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester | |
| SI1436282T1 (en) | Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |